Cargando…
Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker
Mitochondrial serine hydroxylmethyltransferase 2 (SHMT2) is a key enzyme in the serine/glycine synthesis pathway. SHMT2 has been implicated as a critical component for tumor cell survival. The aim of the present study was to evaluate the prognostic value and efficiency of SHMT2 as a biomarker in pat...
Autores principales: | Zhang, Lahong, Chen, Zhaojun, Xue, Dan, Zhang, Qi, Liu, Xiyong, Luh, Frank, Hong, Liquan, Zhang, Hang, Pan, Feng, Liu, Yuhua, Chu, Peiguo, Zheng, Shu, Lou, Guoqiang, Yen, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055214/ https://www.ncbi.nlm.nih.gov/pubmed/27666119 http://dx.doi.org/10.3892/or.2016.5112 |
Ejemplares similares
-
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
por: Wu, Ming, et al.
Publicado: (2017) -
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging
por: Zhu, Zehua, et al.
Publicado: (2022) -
miR-125b inhibited epithelial–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7
por: Hong, Liquan, et al.
Publicado: (2016) -
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
por: Zhang, Hang, et al.
Publicado: (2014) -
Combined Detection of IFN-γ and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times
por: Chen, Yiwen, et al.
Publicado: (2023)